House AWP reform proposal
Rep. Charles Norwood (R-Ga.) introduces AWP reform bill based on "average sales price" April 3. Medicare would pay "120% of the average sales price," defined as "weighted average of all final sales prices to all purchasers." HHS would have discretion to use "cumulative averages sales price" to reimburse for all FDA "A" rated therapeutic equivalents. HR 1622 is similar to legislation sponsored by Rep. Pete Stark (D-Calif.), including proposed $100,000 fine for manufacturers failing to provide HHS with pricing information (1"The Pink Sheet" Jan. 27, p. 9)...
You may also be interested in...
The Centers for Medicare & Medicaid Services will address AWP reform administratively if Congress fails to act by May, CMS Administrator Tom Scully says
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.